Publication | Open Access
ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer
51
Citations
30
References
2016
Year
CRT combined with nelfinavir showed acceptable toxicity and promising survival in pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1